ENLV Enlivex Therapeutics Ltd. - Ordinary Shares
$0.71
Price · May 20, 2026
52W Range
$1–$2
3% of range
Analyst Rating
BUY
7 analysts
Price Target
$20
+2721% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
ENLV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.71
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$1 – $2
ENLV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
ENLV
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
ENLV
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
ENLV
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
ENLV
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
ENLV
Peer Median
ENLV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-05-15
Low
$20.00
High
$20.00
Median target
$20.00
+2720.9%
Mean target
$20.00
+2720.9%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-1.6%
Next Report
May 25, 2026
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2025 | $-7.85 | $-0.03 | -7.8% |
| Sept. 30, 2025 | $-0.09 | $-0.12 | 0.03% |
| June 30, 2025 | $-0.08 | $-0.16 | 0.08% |
| March 31, 2025 | $-0.15 | $-0.16 | 0.01% |
| Dec. 31, 2024 | $-0.23 | $-0.16 | -0.07% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ENLV | — | — | — | — | — | — |
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
| KMDA | — | — | — | — | — | — |
| CGEN | — | — | — | — | — | — |
| ENTX | $90M | 7.8 | -76.8% | -27235.7% | -75.4% | 0.00% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.